Inmode Ltd (INMD) Return on Equity ROE from the fourth quarter 2025 to fourth quarter 2024 and annually, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Inmode Ltd   (NASDAQ: INMD)

Inmode Ltd 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Inmode Ltd in the fourth quarter 2025?
Inmode Ltd achieved a return on average equity (ROE) of 13.73 % in its fourth quarter 2025, which is below Inmode Ltd 's average return on equity, which stands at 27.14%.

ROE fell compared to the third quarter 2025, despite the net income growth of % from the third quarter 2025.

Within the Medical Equipment & Supplies industry 26 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2025 from 444 to 1027.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Equity Change -2.93 % -2.93 % -2.93 % -2.93 % -
Y / Y Net Income Change -48.24 % - - - -8.41 %
Net Income (TTM) in Millions 94 181 181 181 181
Return On Equity (TTM) 13.73 % 26.33 % 26.14 % 25.95 % 25.76 %
INMD's Total Ranking # 1027 # 444 # # #
Equity (TTM) in Millions 683 683 683 683 704
Seq. Equity Change 0 % 0 % 0 % -2.93 % 0 %
Seq. Net Income Change - - - - -

Back to INMD Management Effectiveness >> INMD's 5 Years Annual ROE >> Compare INMD ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 27
Sector # 124
Overall # 1027

Return On Equity Statistics
High Average Low
39.7 %
27.14 %
13.73 %
(Dec 31 2021)   (Dec 31 2025)





INMD Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 683 704 787 555 416
Y / Y Equity Change -2.93 % -10.61 % 41.97 % 33.39 % 62.76 %
Net Income in Millions 94 181 198 162 165
Y / Y Net Income Change -48.24 % -8.41 % 22.54 % -2.15 % 120.03 %
Return On Equity 13.73 % 25.76 % 25.14 % 29.12 % 39.7 %

Back to INMD Management Effectiveness >> INMD's 5 Years Annual ROE >> Compare INMD ROE to its Competitors




Annual Roe Comment
In 2025 ROE decreased compared to the previous year to 13.73 %, due to deterioration of net income.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
INMD's' Return on Equity at Yahoo Finance
INMD's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for INMD's Competitors
Subscribers only: Roe for Inmode Ltd 's Suppliers
Subscribers only: Return On Equity for INMD's Customers




Companies with similar Return On Equity at Dec 31 2025, within Healthcare Sector ROE
Hutchmed china Limited  36.98 %
Oramed Pharmaceuticals Inc  36.81 %
Solventum Corporation  36.74 %
Newgenivf Group Limited  36.53 %
Merck and Co Inc   36.16 %
Adma Biologics Inc   34.98 %
Illumina Inc   34.94 %
Compugen Ltd  34.40 %
Vaxart Inc   33.83 %
Johnson and Johnson  33.78 %
Dexcom Inc   32.44 %
Phibro Animal Health Corporation  32.06 %
Innoviva Inc   30.60 %
Pro dex Inc   30.23 %
Novartis Ag  30.00 %
Incyte Corporation  29.15 %
Waters Corporation  28.52 %
Puma Biotechnology Inc   27.81 %
Resmed Inc   25.18 %
Encompass Health Corporation  24.76 %
Prestige Consumer Healthcare Inc   24.66 %
Catalyst Pharmaceuticals Inc   24.32 %
Collegium Pharmaceutical Inc   24.11 %
Xoma Royalty Corporation  23.97 %
Chemed Corporation  23.92 %
Iradimed Corporation  23.83 %
Lifevantage Corp  23.04 %
Hims and Hers Health Inc   22.99 %
Vertex Pharmaceuticals Inc  22.70 %
Pacs Group Inc   22.54 %

Date modified: 2026-07-07T11:34:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.